This study was undertaken to review the incidence and causes of death in children who have survived long-term (more than 1 year) after liver transplantation (LT).
Summary Background Data
No studies of the causes of late mortality in pediatric LT recipients are currently available in the literature.
Methods
The study group consists of 212 pediatric patients who survived more than 1 year after LT. Twenty-three of these patients subsequently died (mean follow-up = 5.3 yr). Hospital records, office charts, and autopsy records were reviewed retrospectively to identify the causes of death. The patients who died were further evaluated by age, gender, length of survival, primary diagnosis, immunosuppression, and retransplantation.
Results
The most common cause of death was graft failure, followed closely by infection. In patients dying from graft failure, eight of the nine patients underwent retransplantation and no child survived more than three liver transplants. Overwhelming infections occurred suddenly in eight children who had been previously healthy. Noncompliance was the third most common cause of death, primarily in older children. One child died from a posttransplant lymphoproliferative disorder (PTLD) . Actuarial survival at 10 years is 83.7% (based on 100% survival at 1 year). There was no difference in survival based on primary disease. Retransplantation was far more prevalent in the nonsurvivors (47.8%) compared with survivors (13.7%) (p < 0.05). There were no significant differences in survival based on age, gender, or immunosuppression.
Conclusions
Late mortality in children continues to be directly related to complications of LT and immunosuppression, even after the first year of transplantation. This is in contrast to adult liver transplant recipients, where approximately 50% of late deaths were related to LT and the remainder were because of unrelated illnesses. Years Post Transplant Figure 2 . Timing of late deaths after pediatric liver transplant. 4), those with late biliary tract complications (n = 3), and those with recurrent diseases (n = 2; hepatitis B and hepatoblastoma). Of the eight children who died from infection later after LT, five were essentially well and at home at the time of sudden onset of sepsis. The other three died periprocedurally; two after percutaneous cholangiography (patients 13 and 17) and one after appendectomy (patient 16). Only two of these eight had ever received antilymphocyte therapy, none of these eight had been treated for a rejection episode within the 12 months before their death, and two had been retransplanted. Additionally, two of these eight patients underwent splenectomy around the time of transplantation for marked thrombocytopenia. Patient 17 received the pneumococcal vaccine, but patient 10 underwent transplantation and splenectomy before the availability of the vaccine. Enteric organisms grew in blood cultures in two of the patients with spontaneous septic episodes (Enterobacter cloacae, Enterococcus faecalis). Patient 10 grew Hemophilus influenza in blood and sputum cultures postmortem. This patient had undergone splenectomy. Table 2 summarizes many of the characteristics of these children who died from infection.
Four patients died due to noncompliance. Three of these four were teenagers at the time of transplant (14.7, 14.8, and 17 years, respectively). All three stopped taking their immunosuppression 2 to 8 years after LT. One patient, who was transplanted at age 4.6 years, died 5.5 years later when her mother refused to allow medical care. She had recovered from a significant infection, but was severely malnourished and debilitated. Against the recommendations of her local physician the patient was taken home where she died approximately 4 weeks later.
The patient who died secondary to PTLD was 11 Figure 3 reveals the primary diagnoses causing liver failure for the 212 LT recipients. There were no significant differences in the rates of these diagnoses among either long-term survivors or those who died more than 1 year after LT.
Other potential risk factors examined include number of rejection episodes, use of antilymphocyte therapy, and retransplantation (see Tables 3, 4 , 5, and 6). Although approximately 80% of these LT recipients experienced at least one episode of rejection, this did not increase their risk of late mortality (1 or more rejection, survival = 87.2% vs. no rejection, survival = 92.5%; p = 0.45). The use of antilymphocyte therapy also did not affect long- Penn reported that 53% of de novo malignancies in all pediatric organ transplant recipients were lymphomas.8 In this study, only one death was the direct result of malignancy, a de novo lymphoma, leading to death of the recipient 18 months after LT. Penn also reported that the incidence of melanomas, lip cancers, and carcinomas of the vulva, perineum and/or anus were increased in pediatric organ transplant recipients when compared with nonimmunocompromised children.8 There was a notable absence of nonlymphoid malignancies in this study, which may be due in part to the length of follow-up of 5.3 years or to a lower level of chronic immunosuppression in these LT recipients compared with other solid organ transplants.
The causes of late death after pediatric LT, also differ from the causes of late death after adult LT. In adults, infection was a relatively uncommon cause of late death after LT (9%).5 In this study of pediatric LT recipients infection was responsible for 35% of late deaths. Recurrent disease, on the other hand, was a relatively rare cause of late death in pediatric LT recipients, and the most common cause of late mortality in adults. Late deaths from graft failure secondary to chronic rejection, occurred at a similar rate in both adults and pediatric LT recipients (3.1% vs. 3.4%, respectively). Despite improvements in immunosuppression over the last 15 years, graft failure is still the most common cause of death in the pediatric LT recipients long-term. Retransplantation may be an option for patients with late graft failure, however, retransplantation yields significantly lower survival than primary grafts.
Belani, et al. suggested that infants less than 1 year of age are a high risk group for LT, whereas, Dunn, et al.
Ann. Surg. * February 1998 found that age was not a risk factor for survival after LT.9"0 The results reported here are consistent with Dunn's findings that age less than 1 year does not pose increased risk for LT. Similarly, Vazquez examined recipient weight as a risk factor for survival after LT, and as in this series, there was no increased risk for mortality based on recipient weight."
It is widely accepted that splenectomy causes an increased risk of overwhelming infection, perhaps as high as 40 times the risk of the general population.'2 The reported incidence of these infections ranges from 1% to 5%, and is greater in children than adults.'3 The mortality rate reported for patients developing postsplenectomy sepsis is approximately 50%.'3 In this series, only two patients with late mortality had undergone splenectomy, both of whom died from infection. In patient 10 Hemophilus influenza was indeed cultured from the blood and lung at autopsy, and his death occurred within 2 years of transplantation and splenectomy. The postsplenectomy sepsis syndrome is strikingly similar to the septic episodes described for several of the other patients who died from infection. It is not yet clear what increased risk LT recipients will experience, because of lifelong immunosuppression, for other age related causes of mortality such as MI, CVA, and nonlymphoid malignancy. The results of this study would seem to indicate that in the first 5 years after liver transplant there does not appear to be an increased risk of vascular disease or nonlymphoid malignancy in children. This will need to be examined, however, as these children become adults.
CONCLUSIONS
Overall actuarial survival is excellent (84% at 10 years) in those patients who survive more than 1 year post LT. Nevertheless, late deaths continue to be related to complications of immunosuppression. Deaths from infection appear to be unpredictable, therefore every febrile illness should be evaluated early and antibiotic therapy instituted as soon as a bacterial infection is suspected. Protocols for postsplenectomy infection prophylaxis are likewise important, since these spontaneous septic episodes are primarily from gram negative bacteria. Chronic rejection is a common cause of late mortality, that may respond to newer immunosuppressives, but can lead to graft failure requiring retransplantation with its attendant risks. Unlike adults, recurrent disease is not a significant risk factor for late mortality in children after LT, but noncompliance continues to be a critical issue in teenage LT recipients.
